SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-156449
Filing Date
2016-11-14
Accepted
2016-11-14 06:28:21
Documents
79
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-17112_110q.htm 10-Q 1631331
2 EX-31.1 a16-17112_1ex31d1.htm EX-31.1 11193
3 EX-31.2 a16-17112_1ex31d2.htm EX-31.2 10595
4 EX-32.1 a16-17112_1ex32d1.htm EX-32.1 8996
  Complete submission text file 0001104659-16-156449.txt   7172524

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neos-20160930.xml EX-101.INS 1234651
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20160930.xsd EX-101.SCH 69426
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20160930_cal.xml EX-101.CAL 58769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20160930_def.xml EX-101.DEF 306475
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20160930_lab.xml EX-101.LAB 642412
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20160930_pre.xml EX-101.PRE 518630
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 161990257
SIC: 2834 Pharmaceutical Preparations